1.1.2. Articolo in Rivista

1.1.2. Articolo in Rivista - Letter: [927] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 927

Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitors

2025-01-01 Larcher, A.; Capitanio, U.; Necchi, A.; Montorsi, F.; Salonia, A.

Re: ‘Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review’

2026-01-01 Scuderi, S.; Gandaglia, G.; Briganti, A.; Montorsi, F.

One year in: early European adoption of the da Vinci Single Port platform—a multi-institutional study from the European Association of Urology Robotic Urology Section Scientific Working Group

2026-01-01 Pellegrino, F.; Pellegrino, A.; Falagario, U. G.; Tozzi, M.; Weston, R.; Hanchanale, V.; Gandaglia, G.; Briganti, A.; Montorsi, F.; Tuderti, G.; Brassetti, A.; Simone, G.; Izzo, A.; Spena, G.; Contieri, R.; Perdona, S.; Tedde, A.; Madonia, M.; Tappero, S.; Mazzone, E.; Dell'Oglio, P.; Galfano, A.; Decaestecker, K.; Dekuyper, P.; Ameye, F.; Lavagno, F.; Marra, G.; Gontero, P.; Costi, C.; Passaretti, G.; Russo, A.; Gaboardi, F.; Moller, A.; Sundquist, F.; Olsson, M.; Vaccaro, C.; Mistretta, F. A.; Luzzago, S.; Musi, G.; Piccolini, A.; Paciotti, M.; Lughezzani, G.; Buffi, N. M.; Checcucci, E.; Alessio, P.; Amparore, D.; Porpiglia, F.; Marino, F.; Di Gianfrancesco, L.; De Marchi, D.; Porreca, A.; Fankhauser, C.; Ferro, M.; Breda, A.; Crivellaro, S.; Wiklund, P.

Re: Jianliang Liu, Laurence Harewood, Dominic Bagguley, et al. Early Results from the CONFIRM Trial: Utility of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer. Eur Urol Oncol 2025;8:1118-25

2026-01-01 Stabile, A.; Gandaglia, G.; Montorsi, F.

Re: Ken Herrmann, Jochen Walz, Steven MacLennan, et al. SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis. Eur Urol. 2026;89:260–274

2026-01-01 Stabile, A.; Gandaglia, G.; Chiti, A.; Montorsi, F.

Impact of Novel Hormonal Therapy on Cognitive Function: Essential to Measure, Difficult to Present

2022-01-01 Marandino, L.; Raggi, D.; Necchi, A.; Di Maio, M.

Disease progression in myeloproliferative neoplasms: Comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression

2020-01-01 Geyer, J. T.; Margolskee, E.; Krichevsky, S. A.; Cattaneo, D.; Boiocchi, L.; Ronchi, P.; Lunghi, F.; Scandura, J. M.; Ponzoni, M.; Hasserjian, R. P.; Gianelli, U.; Iurlo, A.; Orazi, A.

Anti-cytokine treatment for Takayasu arteritis: State of the art

2014-01-01 Tombetti, E.; Di Chio, M. C.; Sartorelli, S.; Bozzolo, E.; Sabbadini, M. G.; Manfredi, A.; Baldissera, E.

The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Neoadjuvant Immunotherapy

2022-01-01 Martini, A.; Raggi, D.; Marandino, L.; Montorsi, F.; Ross, J. S.; Gibb, E. A.; Necchi, A.

Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer

2020-01-01 D'Andrea, D.; Foerster, B.; Matin, S. F.; Ku, J. H.; Muilwijk, T.; Monteiro, L. L.; Liao, R.; Petros, F. G.; Spiess, P. E.; Bivalacqua, T. J.; Hendricksen, K.; Van Rhijn, B. W. G.; Shabsigh, A.; Briganti, A.; Joniau, S.; Kassouf, W.; Pierorazio, P. M.; Margulis, V.; Necchi, A.; Shariat, S. F.

ACh receptor in ocular MG

1994-01-01 Horton, R. M.; Conti-Tronconi, B. M.; Manfredi, A.

Do putative endogenous digitalis-like factors have a physiological role?

1994-01-01 Hansen, O.; Doris, P. A.; Hamlyn, J. M.; Laredo, J.; Lu, Z. -R.; Hamilton, B.; Lighthall, G.; Manunta, P.

Cytoreductive Nephrectomy in 2021: Obsolete but Necessary

2022-01-01 Capitanio, U.; Necchi, A.; Montorsi, F.; Larcher, A.

Bridging the gap: Phenotype-specific considerations for rituximab therapy in IgG4-related disease. Author's reply

2026-01-01 Lanzillotta, M.; Vikse, J.; Goni, E.; Hoffmann-Vold, A. M.; Della-Torre, E.

Activation state of peripheral T lymphocytes predicts response to abatacept in patients with IgG4-related disease

2025-01-01 Minici, C.; Mahajne, J.; Orfanelli, U.; Lanzillotta, M.; Della-Torre, E.

Ocrelizumab versus ofatumumab efficacy and safety after natalizumab discontinuation in multiple sclerosis: a retrospective real-world comparison

2026-01-01 Marino, V.; Moiola, L.; Zanetta, C.; Rubin, M.; Rossi, L.; Margoni, M.; Nozzolillo, A.; Gattuso, I.; Viti, V.; Petza, E.; Rocca, M. A.; Guerrieri, S.; Filippi, M.

Silent Risk, Real-World Insight From an Italian Center: Rethinking Intracranial Aneurysm Screening in ADPKD

2025-01-01 De Rosa, L. I.; Catania, M.; Kristiana, K.; Paolisi, M.; Bianca, P.; Farinone, S.; Manunta, P.; Vezzoli, G.; Sciarrone Alibrandi, M. T.

SunRISe-4 perioperative safety and TURBT stratification – Authors' reply

2025-01-01 Necchi, A.; Stitou, H.; Bhanvadia, S.; Psutka, S. P.

Patient selection for prostate cancer focal therapy guided by mpMRI–PSMA PET concordance and pathology review

2026-01-01 Stabile, A.; Brancaccio, M.; Scilipoti, P.; Barletta, F. M.; Scuderi, S.; Quarta, L.; Cosenza, A.; Zaurito, P.; Porzi, M. E.; Imperiale, G.; Brembilla, G.; Cobelli, F. D.; Pini, C.; Chiti, A.; Colecchia, M.; Montorsi, F.; Gandaglia, G.; Briganti, A.

Beyond surgical technique: modifiable risk factors and evolving treatment paradigms in bladder cancer surgery

2026-01-01 Scilipoti, P.; Rosiello, G.; Salonia, A.; Briganti, A.; Necchi, A.; Moschini, M.; Montorsi, F.

Titolo	Data di pubblicazione	Autore(i)
Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitors	1-gen-2025	Larcher, A.; Capitanio, U.; Necchi, A.; Montorsi, F.; Salonia, A.
Re: ‘Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review’	1-gen-2026	Scuderi, S.; Gandaglia, G.; Briganti, A.; Montorsi, F.
One year in: early European adoption of the da Vinci Single Port platform—a multi-institutional study from the European Association of Urology Robotic Urology Section Scientific Working Group	1-gen-2026	Pellegrino, F.; Pellegrino, A.; Falagario, U. G.; Tozzi, M.; Weston, R.; Hanchanale, V.; Gandaglia, G.; Briganti, A.; Montorsi, F.; Tuderti, G.; Brassetti, A.; Simone, G.; Izzo, A.; Spena, G.; Contieri, R.; Perdona, S.; Tedde, A.; Madonia, M.; Tappero, S.; Mazzone, E.; Dell'Oglio, P.; Galfano, A.; Decaestecker, K.; Dekuyper, P.; Ameye, F.; Lavagno, F.; Marra, G.; Gontero, P.; Costi, C.; Passaretti, G.; Russo, A.; Gaboardi, F.; Moller, A.; Sundquist, F.; Olsson, M.; Vaccaro, C.; Mistretta, F. A.; Luzzago, S.; Musi, G.; Piccolini, A.; Paciotti, M.; Lughezzani, G.; Buffi, N. M.; Checcucci, E.; Alessio, P.; Amparore, D.; Porpiglia, F.; Marino, F.; Di Gianfrancesco, L.; De Marchi, D.; Porreca, A.; Fankhauser, C.; Ferro, M.; Breda, A.; Crivellaro, S.; Wiklund, P.
Re: Jianliang Liu, Laurence Harewood, Dominic Bagguley, et al. Early Results from the CONFIRM Trial: Utility of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer. Eur Urol Oncol 2025;8:1118-25	1-gen-2026	Stabile, A.; Gandaglia, G.; Montorsi, F.
Re: Ken Herrmann, Jochen Walz, Steven MacLennan, et al. SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis. Eur Urol. 2026;89:260–274	1-gen-2026	Stabile, A.; Gandaglia, G.; Chiti, A.; Montorsi, F.
Impact of Novel Hormonal Therapy on Cognitive Function: Essential to Measure, Difficult to Present	1-gen-2022	Marandino, L.; Raggi, D.; Necchi, A.; Di Maio, M.
Disease progression in myeloproliferative neoplasms: Comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression	1-gen-2020	Geyer, J. T.; Margolskee, E.; Krichevsky, S. A.; Cattaneo, D.; Boiocchi, L.; Ronchi, P.; Lunghi, F.; Scandura, J. M.; Ponzoni, M.; Hasserjian, R. P.; Gianelli, U.; Iurlo, A.; Orazi, A.
Anti-cytokine treatment for Takayasu arteritis: State of the art	1-gen-2014	Tombetti, E.; Di Chio, M. C.; Sartorelli, S.; Bozzolo, E.; Sabbadini, M. G.; Manfredi, A.; Baldissera, E.
The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Neoadjuvant Immunotherapy	1-gen-2022	Martini, A.; Raggi, D.; Marandino, L.; Montorsi, F.; Ross, J. S.; Gibb, E. A.; Necchi, A.
Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer	1-gen-2020	D'Andrea, D.; Foerster, B.; Matin, S. F.; Ku, J. H.; Muilwijk, T.; Monteiro, L. L.; Liao, R.; Petros, F. G.; Spiess, P. E.; Bivalacqua, T. J.; Hendricksen, K.; Van Rhijn, B. W. G.; Shabsigh, A.; Briganti, A.; Joniau, S.; Kassouf, W.; Pierorazio, P. M.; Margulis, V.; Necchi, A.; Shariat, S. F.
ACh receptor in ocular MG	1-gen-1994	Horton, R. M.; Conti-Tronconi, B. M.; Manfredi, A.
Do putative endogenous digitalis-like factors have a physiological role?	1-gen-1994	Hansen, O.; Doris, P. A.; Hamlyn, J. M.; Laredo, J.; Lu, Z. -R.; Hamilton, B.; Lighthall, G.; Manunta, P.
Cytoreductive Nephrectomy in 2021: Obsolete but Necessary	1-gen-2022	Capitanio, U.; Necchi, A.; Montorsi, F.; Larcher, A.
Bridging the gap: Phenotype-specific considerations for rituximab therapy in IgG4-related disease. Author's reply	1-gen-2026	Lanzillotta, M.; Vikse, J.; Goni, E.; Hoffmann-Vold, A. M.; Della-Torre, E.
Activation state of peripheral T lymphocytes predicts response to abatacept in patients with IgG4-related disease	1-gen-2025	Minici, C.; Mahajne, J.; Orfanelli, U.; Lanzillotta, M.; Della-Torre, E.
Ocrelizumab versus ofatumumab efficacy and safety after natalizumab discontinuation in multiple sclerosis: a retrospective real-world comparison	1-gen-2026	Marino, V.; Moiola, L.; Zanetta, C.; Rubin, M.; Rossi, L.; Margoni, M.; Nozzolillo, A.; Gattuso, I.; Viti, V.; Petza, E.; Rocca, M. A.; Guerrieri, S.; Filippi, M.
Silent Risk, Real-World Insight From an Italian Center: Rethinking Intracranial Aneurysm Screening in ADPKD	1-gen-2025	De Rosa, L. I.; Catania, M.; Kristiana, K.; Paolisi, M.; Bianca, P.; Farinone, S.; Manunta, P.; Vezzoli, G.; Sciarrone Alibrandi, M. T.
SunRISe-4 perioperative safety and TURBT stratification – Authors' reply	1-gen-2025	Necchi, A.; Stitou, H.; Bhanvadia, S.; Psutka, S. P.
Patient selection for prostate cancer focal therapy guided by mpMRI–PSMA PET concordance and pathology review	1-gen-2026	Stabile, A.; Brancaccio, M.; Scilipoti, P.; Barletta, F. M.; Scuderi, S.; Quarta, L.; Cosenza, A.; Zaurito, P.; Porzi, M. E.; Imperiale, G.; Brembilla, G.; Cobelli, F. D.; Pini, C.; Chiti, A.; Colecchia, M.; Montorsi, F.; Gandaglia, G.; Briganti, A.
Beyond surgical technique: modifiable risk factors and evolving treatment paradigms in bladder cancer surgery	1-gen-2026	Scilipoti, P.; Rosiello, G.; Salonia, A.; Briganti, A.; Necchi, A.; Moschini, M.; Montorsi, F.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 927

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext431
reserved348
open147
partially open1